1. Home
  2. STTK vs ACB Comparison

STTK vs ACB Comparison

Compare STTK & ACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$6.00

Market Cap

275.9M

Sector

Health Care

ML Signal

HOLD

Logo Aurora Cannabis Inc.

ACB

Aurora Cannabis Inc.

HOLD

Current Price

$3.44

Market Cap

250.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STTK
ACB
Founded
2016
2013
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Pharmaceuticals and Biotechnology
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
275.9M
250.1M
IPO Year
2020
2016

Fundamental Metrics

Financial Performance
Metric
STTK
ACB
Price
$6.00
$3.44
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$7.60
N/A
AVG Volume (30 Days)
589.2K
563.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
53.02
N/A
EPS
N/A
N/A
Revenue
$1,000,000.00
N/A
Revenue This Year
N/A
$6.89
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.69
$3.28
52 Week High
$6.27
$6.67

Technical Indicators

Market Signals
Indicator
STTK
ACB
Relative Strength Index (RSI) 71.72 41.26
Support Level $1.85 $3.28
Resistance Level N/A $3.91
Average True Range (ATR) 0.42 0.13
MACD 0.09 0.00
Stochastic Oscillator 89.41 7.11

Price Performance

Historical Comparison
STTK
ACB

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About ACB Aurora Cannabis Inc.

Aurora Cannabis Inc headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company operates in Canada, it has expanded internationally through medical cannabis exporting agreements. The company opertes in Canada, Europe, Australia, and Others, with majority revenue from Canada.

Share on Social Networks: